Bob Smith says the market is finally moving his way. Smith runs T. Rowe Price Growth Stock (PRGFX), which invests principally in large growth companies, a sector of the market that has been shunned for more than six years. "Even value investors think growth is where the cheapest stocks are now," he says.
Although the markets haven't cooperated with his sector in recent years, his fund, a member of the Kiplinger 25, has posted a fine record. Growth Stock returned 9% annualized in the decade through April 13, beating the average large-cap fund by more than three percentage points per year.
Alas, Smith is moving on just as his bailiwick is showing signs of life. He'll become portfolio manager of T. Rowe Price International Stock, a relative laggard, on October 1. He'll be replaced at the helm of Growth Stock by Robert Bartolo, co-manager of T. Rowe Price Media and Telecommunications, an excellent sector fund. We'll revisit the fund later this year to determine whether it should remain on our recommended list after Smith leaves.
From just $107.88 $24.99 for Kiplinger Personal Finance
Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Smith looks for businesses that can sustain earnings growth of 12% to 15% a year for five years. "Very few companies can grow 15% for five years," he says. Corporations that achieve these numbers are probably expanding unit volumes, raising prices and quite possibly gaining market share. In a slowing economy, such as we have today, the market will often pay a premium for large-cap growth companies such as these that can keep up the pace in a weaker economy. But, Smith stresses, he won't overpay for growth. "Every fundamental investor is a value investor," he says.
So where does he find value in growth stocks these days? His largest position is in Accenture (ACN), the big consulting and information-technology-services outfit that sports a towering return on equity. He's avoiding shares of big drug manufacturers but has large positions in medical insurer UnitedHealth Group (UNH); Medtronic (MDT), the heart pacemaker king; CVS (CVS), the drug-store chain; and Genentech (DNA), a leading biotechnology firm.
Two other growth themes he likes are the Internet -- Google (GOOG) is a top holding -- and telecommunications, Qualcomm (QCOM) and Cisco Systems (CSCO). He's also buying businesses with strong overseas operations, such as AIG, Schlumberger (SLB) and Wynn Resorts (WYNN).
-
Stocks Chop as the Unemployment Rate Jumps: Stock Market TodayNovember job growth was stronger than expected, but sharp losses in October and a rising unemployment rate are worrying market participants.
-
Should You Renew Your CD?With rate cuts impacting earnings, we examine if now is a wise time to renew CDs.
-
7 Ways to Plan Now to Save on Medicare IRMAA Surcharges LaterUnderstand the critical two-year lookback period and why aggressive planning before you enroll in Medicare is the most effective way to minimize IRMAA.
-
The 5 Best Actively Managed Fidelity Funds to Buy and Holdmutual funds Sometimes it's best to leave the driving to the pros – and these actively managed Fidelity funds do just that, at low costs to boot.
-
The 12 Best Bear Market ETFs to Buy NowETFs Investors who are fearful about the more uncertainty in the new year can find plenty of protection among these bear market ETFs.
-
Don't Give Up on the Eurozonemutual funds As Europe’s economy (and stock markets) wobble, Janus Henderson European Focus Fund (HFETX) keeps its footing with a focus on large Europe-based multinationals.
-
Vanguard Global ESG Select Stock Profits from ESG Leadersmutual funds Vanguard Global ESG Select Stock (VEIGX) favors firms with high standards for their businesses.
-
Kip ETF 20: What's In, What's Out and WhyKip ETF 20 The broad market has taken a major hit so far in 2022, sparking some tactical changes to Kiplinger's lineup of the best low-cost ETFs.
-
ETFs Are Now Mainstream. Here's Why They're So Appealing.Investing for Income ETFs offer investors broad diversification to their portfolios and at low costs to boot.
-
Do You Have Gun Stocks in Your Funds?ESG Investors looking to make changes amid gun violence can easily divest from gun stocks ... though it's trickier if they own them through funds.
-
How to Choose a Mutual Fundmutual funds Investors wanting to build a portfolio will have no shortage of mutual funds at their disposal. And that's one of the biggest problems in choosing just one or two.
